Stock A388870 PHAROS IBIO CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Pharos iBio Co., Ltd.

Equities

A388870

KR7388870008

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 01/07/2024 BST 		5-day change 1st Jan Change
11,020 KRW -4.17% Intraday chart for Pharos iBio Co., Ltd. -0.99% -25.69%
2023 Pharos Therapeutics INC announced that it has received KRW 1.3523 billion in funding from Pharos iBio Co., Ltd. CI
2023 Pharos Therapeutics INC announced that it expects to receive KRW 1.3523 billion in funding from Pharos iBio Co., Ltd. CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PHAROS IBIO CO., LTD. Stock Pharos iBio Co., Ltd.
 103M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 122B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 113B
ARGENX SE Stock argenx SE
 26.22B -
BIONTECH SE Stock BioNTech SE
 19.01B -
GENMAB A/S Stock Genmab A/S
 15.71B
  1. Stock Market
  2. Equities
  3. A388870 Stock
  4. Charts Pharos iBio Co., Ltd.
  5. Sector Chart